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ABSTRAK
Apnea tidur obstruktif (ATO) merupakan gangguan pernafasan saat tidur yang ditandai dengan adanya 
episode obstruktif saluran pernafasan total atau sebagian, yang mengakibatkan terjadinya apnea atau hipopnea. 
ATO dapat berperan dalam proses terjadinya aterosklerosis melalui mekanisme langsung maupun tidak langsung.
Disfungsi endotel, stimulasi saraf simpatik, dan modulasi sitokin proinflamasi yang disebabkan oleh ATO 
mempunyai peran yang signifikan dalam terjadinya proses aterosklerosis. Faktor-faktor resiko aterosklerosis 
lain seperti hipertensi dan diabetes mellitus juga berhubungan dengan ATO. Studi eksperimental dan klinis 
telah menunjukkan data yang mendukung adanya asosiasi antara ATO, aterosklerosis, dan faktor-faktor resiko 
terkait. Akan tetapi, masih terdapat inkonsistensi pada hasil data yang terkumpul hingga saat ini. Di masa yang 
akan datang, dibutuhkan penelitian dasar dan klinis lebih lanjut terkait hal ini.
Kata kunci: apnea tidur obstruktif, aterosklerosis.
ABSTRACT
Obstructive sleep apnea (OSA) is a sleep respiratory disorder characterized by recurrent episodes of complete 
or partial airway obstruction, resulting in apneas or hypopneas. OSA could contribute to atherosclerosis through 
direct and indirect mechanisms.
Endothelial dysfunction, sympathetic stimulation, and proinflammatory cytokine modulation caused by 
OSA play significant role to an atherosclesrotic event. Other risk factors of atherosclerosis like hypertension 
and diabetes mellitus also associated with OSA. Animal and clinical studies recently showed promising data to 
prove association between OSA, atherosclerosis, and its risk factors. However, provided data has not showed 
consistent result. In the future, demand of further research both basic and clinical sciences need to be fulfilled.
Keywords: obstructive sleep apnea, atherosclerosis.
INTRODUCTION
Obstructive sleep apnea (OSA) is a 
sleep respiratory disorder characterized by 
recurrent episodes of complete or partial airway 
obstruction, resulting in apneas or hypopneas.1,2 
This condition that associated with intermittent 
arterial oxygen desaturation is occurred in 
approximately 9-24% of the general population.3 
The consequences of this condition are increased 
expression of systemic inflammation markers, 
activation of sympathetic nervous system, 
and endothelial dysfunction.4,5 These could be 
implicated and associated with pathogenesis and 
pathophysiology of atherosclerosis.6
Atherosclerosis has been recognized as 
an inflammatory disease of the arterial wall, 
involving innate and adaptive immunity.7 Many 
evidences had shown association between OSA 
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and atherosclerosis.8-11 The OSA syndrome is 
defined as more than five apneas (no breath flow 
for more than 10s)/hypopnea index (reduced 
breath flow) per hour (so called apnea/hypopnea 
index: AHI) in polysomnography followed by 
symptoms like loud snoring, breathing stoppage, 
nocturia, headache, excessive daytime sleepiness, 
deficits in memory, and attention with subsequent 
risk of accident by day.8 OSA could contribute 
to atherosclerosis through direct and indirect 
mechanisms. This review will briefly explain the 
association of OSA and atherosclerosis.
O S A  D I R E C T  M E C H A N I S M S  T O 
ATHEROSCLEROSIS
OSA could promote atherosclerosis directly 
through neural, vascular, mechanic, and 
inflammatory pathways. Through the neural 
pathway, it is believed that OSA could stimulate 
sympathetic nerves, resulting catecholamine 
substances release in the blood plasma and urine.4 
Grassi et al12 study compared four groups of 
non-OSA lean group, OSA lean group, non-OSA 
obese group, and OSA obese group with total 
consisting of 86 middle-aged and normotensive 
subjects. After matching the age, sex, and blood 
pressure within all groups, in the OSA-lean group 
and non-OSA obese group, there were similar 
increased of muscle sympathetic nerve activity 
compared to non-OSA lean group. In the OSA 
obese group, further increased of sympathetic 
activity was found respectively. These results 
suggested sympathetic activation in obese 
patients occurring independently of OSA, but 
OSA has an additive sympathetic stimulation 
effect.12
OSA could also contribute to the derangement 
of endothelial function. Oxidative stress is one of 
the main causes of endothelial dysfunction.13 Study 
from Jelic et al14 to evaluate oxidative damage 
from 32 OSA and 15 control subjects showed that 
endothelial expression of endothelial nitric oxide 
synthetase (eNOS) and phosphorylated eNOS 
decreased by 59% and 94% in untreated OSA 
patients. Phosphorylated eNOS is the enzyme 
active form for producing nitric oxide (NO) in 
vasculature. Whereas nitrotyrosine known as 
oxidative stress marker and cyclooxygenase-2 
known as inflammation marker found to be 
5-fold greater in OSA patients. However, when 
the subjects adhered to gold standard therapy of 
OSA that is continuous positive airway pressure 
(CPAP), the expression of nitrotyrosine and 
cyclooxygenase-2 was decreased significantly, 
hence restoring eNOS and phosphorylated 
NOS.14 Many mechanisms have been suggested 
for endothelial dysfunction due to OSA which 
are interaction on NO and reactive oxygen 
species (ROS) forming peroxynitrite, uncoupling 
of eNOS, decreased endothelial expression of 
eNOS, and increased levels of endogenous eNOS 
inhibitors.15 Diminished endothelial function is 
an important consequences of OSA leading to 
atherosclerosis formation.5,16
Endothelial dysfunction also promotes 
proinflammatory mediators such as TNF-a, 
IL-1, IL-8, and adhesion molecules, resulting 
in an environment of systemic inflammation.17 
These sequence processes hence resulting in 
accumulating and recruiting of macrophages and 
fat cells that further activates lipid peroxidation 
and promotes endothelial cell damage and 
atherosclerosis.18-19
The other OSA direct mechanism to 
atherosclerosis is through the mechanical pathway. 
OSA could result in apneas or hypopneas. The 
first symptom is an abrupt of inspiratory effort. In 
accordance to this, a sudden increase in negative 
intra-thoracic pressure resulting an increased in 
left ventricular transmural pressure (a component 
of ventricular afterload), left atrial wall tension, 
and venous return to right ventricle is occurred, 
hence reducing stroke volume due to impeded 
left ventricular filling by leftward shift of the 
interventricular septum. With standstill airflow, 
all these sequences events are causing declined of 
arterial oxygen and increased of carbon dioxide, 
resulting in mismatch of myocardial oxygen 
supply and demand.20-21 Imposed of oxidative 
stress regarding the aforementioned events could 
promote and predispose atherosclerosis.21-22 
Moreover, even snoring has been postulated as 
an atherogenic factor recently.23 This could be 
possible because snoring vibration is transmitted 
through the surrounding tissues of carotid 
artery wall, triggering an inflammation cascade 
which leads to atherosclerosis.1 However, the 
aforementioned evidence points to an association 
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rather than definitive cause-effect relationships 
between snoring and atherosclerosis.24
O S A I N D I R E C T  M E C H A N I S M S  T O 
ATHEROSCLEROSIS
Atherosclerosis progression also could occur 
through OSA indirect mechanisms.1 OSA is now 
recognized to be an independent risk factor for 
daytime hypertension.25 From OSA patients, 
close to 35% have hypertension, whereas 30% 
who have OSA are undiagnosed.26-27 Wisconsin 
Sleep Cohort study from Peppard et al28 found 
a causal association between sleep disordered 
breathing (SDB) and hypertension events by 
four years later in 709 subjects. Moreover, 
increasing baseline AHI increased the odds of 
hypertension. This association was independent 
of age, sex, body mass index (BMI), waist and 
neck circumference, baseline hypertension, 
smoking, and alcohol use.28 Sleep Heart Health 
Study also supported the aforementioned study. 
A cross-sectional analysis revealed subjects with 
an AHI >30 events/hour had 1.37-fold increased 
odds of hypertension compared to those without 
OSA (AHI <1.5 per hour) after adjusting for 
several confounders.29 Other evidence also 
supported cause-effect relationship between OSA 
and hypertension. The trial showed ameliorative 
effect of hypertension of patients undergoing 
CPAP.30
OSA had also an independent association 
with insulin resistance and type 2 diabetes in 
many studies.31-34 Chronic intermittent hypoxia 
(IH) observed in OSA had been linked to the 
development of insulin resistance and pancreatic 
beta cell dysfunction.35 Studies from animal 
models also supported the aforementioned 
data.36-37 Fasting hyperglycemia, glucose 
intolerance, and insulin resistance in both mice 
with diet-induced obesity and mice with genetic 
obesity is exacerbated by chronic IH.36-37 In lipid 
metabolism, OSA animal models has shown 
fasting dyslipidemia in both lean and obese mice 
induced by chronic IH due to activation of the 
transcription factor sterol regulatory element-
binding protein 1 and an important downstream 
enzyme of triglyceride and phospholipid 
biosynthesis, stearoyl-CoA desaturase-1.38-40 
Moreover, in randomized humans study, revealed 
that CPAP treatment in OSA patients improved 
triglyceride and cholesterol levels.41 However, 
there are no consistent data suggesting that 
OSA is a major risk factor for dyslipidemia.42 
Further studies need to be established to elucidate 
OSA association with metabolic dysregulation 
especially dyslipidemia.43
Figure 1. Effect on obstructive sleep apnea on coronary 
vasculature.43 (Adapted with permission)
C L I N I C A L S T U D I E S  O F  O S A A N D 
ATHEROSCLEROSIS
Many evidence have shown significant 
association between OSA and atherosclerosis.6,44-45 
Meta-analyses by Nadeem et al6 revealed that 
patients with OSA showed an increased carotid 
intima media thickness (CIMT) suggestive 
an atherosclerotic process. Total 95 studies 
were reviewed, with 16 studies being pooled 
for analyses containing 25 data sets of 1415 
patients.6 Other prospective cohort study 
called Multi-Ethnic Study Atherosclerosis 
(MESA) consisted of 2603 subjects being 
evaluated to know the association between 
OSA and progression of coronary artery 
calcium (CAC) also support the result study 
aforementioned.44 The study was performed by 
subjects completing a sleep questionnaire and 
underwent coronary computed tomography (CT), 
and then after 8 years, the same CT examination 
was done again.44 This study concluded that OSA 
was associated with CAC score progression 
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after adjustment for demographic, behaviors, 
ad body mass index (BMI). Although the 
association was not significant after adjustment 
for cardiovascular risk factors, it suggested the 
association between OSA and CAC.44 Parameters 
above mentioned like CIMT and CAC are marker 
for atherosclerosis formation.
CONCLUSION
Current evidence reveal OSA as an important 
cause of atherosclerosis formation. Direct and 
indirect mechanisms of OSA could contribute as 
aggravating factors of atherosclerosis. Endothelial 
dysfunction, sympathetic stimulation, and 
proinflammatory cytokine modulation caused by 
OSA play significant role to an atherosclesrotic 
event. Other risk factors of atherosclerosis 
like hypertension and diabetes mellitus also 
are associated with OSA. Animal and clinical 
studies recently showed promising data to prove 
association between OSA, atherosclerosis, and 
its risk factors. However, provided data has 
not showed consistent result. In the future, 
demand for further research both basic and 
clinical sciences need to be fulfilled. Basic 
science research will clearly define OSA and all 
pathogenesis to atherosclerosis in the molecular 
level, whereas clinical research will help us to 
know the impact of OSA to atherosclerosis. 
Hence, early diagnosis and treatment of OSA 
will definitely decrease atherosclerosis morbidity 
and mortality. 
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